// App-Quantinova.ai

: PD-L1 Testing of EBUS-TBNA Samples Acquired for the Diagnosis and Staging of Non-Small Cell Lung Cancer: Feasibility and Results

Researchers

Presenter

  • A. Smith

Principal Investigators

  • H. Wang

  • A. Zerbo

  • S. Beaudoin

  • L. M. Ofiara

  • A. Benedetti

  • A. V. Gonzalez

Medical Centers

  • Research Institute McGill University Health Center, Montreal, Quebec, Canada

  • Divisions of Pathology and Molecular Genetics, Optilab, McGill University Health Centre, Montreal, QC, Canada,

  • Respiratory Division, McGill University Health Centre, Montreal, QC, Canada.

  • Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

  • Tissue polypeptide-specific antigen

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved